4.8 Article

Hypercalcemia and Cancer: Differential Diagnosis and Treatment

Journal

CA-A CANCER JOURNAL FOR CLINICIANS
Volume 68, Issue 5, Pages 377-386

Publisher

WILEY
DOI: 10.3322/caac.21489

Keywords

evaluation; malignancy; management; paraneoplastic syndrome

Categories

Ask authors/readers for more resources

Incidentally detected hypercalcemia usually presents in an indolent manner and is most likely caused by primary hyperparathyroidism. In contrast, hypercalcemia in the patient with a history of cancer presents in a wide range of clinical settings and may be severe enough to warrant hospitalization. This form of hypercalcemia is usually secondary to hypercalcemia of malignancy and can be fatal. Hypercalcemia of malignancy is most commonly mediated by tumoral production of parathyroid hormone-related protein or by cytokines activating osteoclast degradation of bone. The initial workup, differential diagnoses, confirmatory laboratory testing, imaging, and medical and surgical management of hypercalcemia are described in the patient with cancer. (C) 2018 American Cancer Society.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available